Brown Miller Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SRIM
SAM
GA
QI
AA
OFA
PM
PFS
AIP
Brown Miller Wealth Management's NVO Position: Q2 2026 in Review
Brown Miller Wealth Management increased its Novo Nordisk (NVO) stake by 3% in Q2 2026, buying an estimated $18.5K and bringing the position to 14,950 shares worth $717K. The position accounts for 0.18% of the portfolio, ranked #95.
Brown Miller Wealth Management first reported a position in NVO in Q1 2024 and has held it in 8 quarters since. The position peaked at $943K in Q2 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Brown Miller Wealth Management held 14,950 shares of Novo Nordisk worth $717K as of Q2 2026.
- Brown Miller Wealth Management bought 430 Novo Nordisk shares in Q2 2026, an estimated $18.5K.
- Novo Nordisk made up 0.18% of Brown Miller Wealth Management's portfolio in Q2 2026, its #95 holding.
- Brown Miller Wealth Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 8 quarters since.
- Brown Miller Wealth Management's Novo Nordisk position peaked at $943K in Q2 2025.
- 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.